Skip to content
Investment Visual

HCA

HCA Healthcare, Inc.

$499.05−1.61 (−0.32%)Close Nov 13, 2026

Backtest HCA

Insider trading

12 months to Nov 10, 2026
Sold
$47.5M
8 insiders
Largest seller
$21.5M
Samuel N. Hazen · 45% of sales
Bought
$0
No buys
Latest buy
Jul 25, 2022
Patricia F. Elcan, 10% owner

Buys and sales on the price

Since 2003

By period

Open-market trades
Trades3 months12 monthsSince 2003
Buys0072
Sales49654
Plan sales00132
Shares bought00001,780,9541.78M
Shares sold36,41336.4K94,50494.5K835,181,723835M
Net shares−36,413−36.4K−94,504−94.5K−833,400,769−833M
Net value−$18.3M−$47.5M−$33.2B

Insiders

Insider12 monthsShares held
William R. Frist
Director, 10% owner
—
120,677,310
as of Apr 30, 2026
Thomas F. Frist Jr
10% owner
—
69,318,985
as of Feb 10, 2026
Patricia F. Elcan
10% owner
—
69,033,374
Thomas F. Frist III
Director, 10% owner
—
68,855,888
Frisco II
10% owner
—
36,557,141
as of Feb 10, 2026

Trades

726 trades since 2003
TypeInsiderRoleSharesPriceHeld after
Nov 10, 2026Sale
Erica RossittoSVP & Chief Nurse Executive
SVP & Chief Nurse Executive
SVP & Chief Nurse Executive
3,500
at $505.81
$505.81$1.77M
−20.7%
13.4K after
13,426
Nov 6, 2026Sale
Jon M. FosterEVP and COO
EVP and COO
EVP and COO
21,713
at $494.95
$494.95$10.7M
−10.9%
Changed by trades not shown: 178K after
Changed by trades not shown: 178,374
Nov 4, 2026Sale
Michael J. SchlosserEVP and Chief Clinical Officer
EVP and Chief Clinical Officer
EVP and Chief Clinical Officer
1,200
at $494.65
$494.65$594K
−12.5%
8.39K after
8,394
Nov 4, 2026Sale
Jon M. FosterEVP and COO
EVP and COO
EVP and COO
10,000
at $514.07
$514.07$5.14M
−4.7%
201K after
200,658
Feb 18, 2026Sale
Michael R. McAleveyEVP & Chief Legal & Admin Off.
EVP & Chief Legal & Admin Off.
EVP & Chief Legal & Admin Off.
1,694
at $533.37
$533.37$904K
−13.4%
Changed by trades not shown: 11.0K after
Changed by trades not shown: 10,990
Feb 11, 2026Sale
Christopher F. WyattSVP & Controller
SVP & Controller
SVP & Controller
4,000
at $505.00
$505.00$2.02M
−8.3%
44.4K after
44,379
Feb 11, 2026Sale
Jennifer BerresSVP & Chief Human Res. Officer
SVP & Chief Human Res. Officer
SVP & Chief Human Res. Officer
8,020
at $514.58
$514.58$4.13M
−40.1%
12.0K after
11,993
Feb 3, 2026Sale
Samuel N. HazenCEO, Director
CEO, Director
CEO, Director
42,877
at $501.04
$501.04$21.5M
−3.1%
1.35M after
1,348,683
Feb 3, 2026Sale
Michael S. CuffeEVP and Chief Clinical Officer
EVP and Chief Clinical Officer
EVP and Chief Clinical Officer
1,500
at $498.09
$498.09$747K
−4.8%
30.0K after
30,003
Nov 5, 2025Sale
Michael R. McAleveyEVP & Chief Legal & Admin Off.
EVP & Chief Legal & Admin Off.
EVP & Chief Legal & Admin Off.
3,892
at $473.79
$473.79$1.84M
−40.9%
5.62K after
5,624
  • Erica Rossitto$1.77M
    Nov 10, 2026 · Sale3,500 at $505.81
    SVP & Chief Nurse Executive−20.7% of holdings, 13.4K after
  • Jon M. Foster$10.7M
    Nov 6, 2026 · Sale21,713 at $494.95
    EVP and COO−10.9% of holdings, Changed by trades not shown: 178K after
  • Michael J. Schlosser$594K
    Nov 4, 2026 · Sale1,200 at $494.65
    EVP and Chief Clinical Officer−12.5% of holdings, 8.39K after
  • Jon M. Foster$5.14M
    Nov 4, 2026 · Sale10,000 at $514.07
    EVP and COO−4.7% of holdings, 201K after
  • Michael R. McAlevey$904K
    Feb 18, 2026 · Sale1,694 at $533.37
    EVP & Chief Legal & Admin Off.−13.4% of holdings, Changed by trades not shown: 11.0K after
  • Christopher F. Wyatt$2.02M
    Feb 11, 2026 · Sale4,000 at $505.00
    SVP & Controller−8.3% of holdings, 44.4K after
  • Jennifer Berres$4.13M
    Feb 11, 2026 · Sale8,020 at $514.58
    SVP & Chief Human Res. Officer−40.1% of holdings, 12.0K after
  • Samuel N. Hazen$21.5M
    Feb 3, 2026 · Sale42,877 at $501.04
    CEO, Director−3.1% of holdings, 1.35M after
  • Michael S. Cuffe$747K
    Feb 3, 2026 · Sale1,500 at $498.09
    EVP and Chief Clinical Officer−4.8% of holdings, 30.0K after
  • Michael R. McAlevey$1.84M
    Nov 5, 2025 · Sale3,892 at $473.79
    EVP & Chief Legal & Admin Off.−40.9% of holdings, 5.62K after